ESR1 and breast carcinoma: The genes involved in cytoskeleton and integrin signaling pathways were significantly upregulated in breast CAFs isolated from HER2-overexpressing breast cancers when compared to those isolated from triple-negative breast cancers or estrogen receptor-positive breast tumors.